The pathological effects of cerebral amyloid angiopathy (CAA, vascular Aβ accumulation) in AD have been thoroughly studied [111], whereas the impact of tau on vascular pathology in AD has only recently started to draw the attention of the scientific community. The gene discussed is MAPT; the disease is cerebral amyloid angiopathy.